Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2005 5
2007 1
2008 2
2009 2
2010 6
2011 11
2012 9
2013 3
2014 9
2015 6
2016 10
2017 9
2018 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement.
Nagakawa Y, Hosokawa Y, Nakayama H, Sahara Y, Takishita C, Nakajima T, Hijikata Y, Kasuya K, Katsumata K, Tokuuye K, Tsuchida A. Nagakawa Y, et al. Among authors: kasuya k. Cancer Chemother Pharmacol. 2017 May;79(5):951-957. doi: 10.1007/s00280-017-3288-7. Epub 2017 Apr 4. Cancer Chemother Pharmacol. 2017. PMID: 28378027 Clinical Trial.
Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
Itoi T, Sugimoto M, Umeda J, Sofuni A, Tsuchiya T, Tsuji S, Tanaka R, Tonozuka R, Honjo M, Moriyasu F, Kasuya K, Nagakawa Y, Abe Y, Takano K, Kawachi S, Shimazu M, Soga T, Tomita M, Sunamura M. Itoi T, et al. Among authors: kasuya k. Int J Mol Sci. 2017 Apr 4;18(4):767. doi: 10.3390/ijms18040767. Int J Mol Sci. 2017. PMID: 28375170 Free PMC article.
79 results